Shelley Aldred, Founder of Rondo Therapeutics

Shelley Aldred is the founder of Rondo Therapeutics. Rondo Therapeutics has raised $67M in total funding. Latest round: Series A.

About Shelley Aldred

Shelley Aldred is the co-founder and chief executive officer of Rondo Therapeutics, a biopharmaceutical company focused on developing next-generation immuno-oncology platforms for treating solid tumors. The company closed an oversubscribed $67 million Series A financing round in March 2022. Aldred is a repeat entrepreneur with deep expertise in bispecific antibody discovery, having co-founded and led multiple successful biotechnology companies.

Shelley Aldred at a glance

More founders in San Francisco, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library